A
Azeria Therapeutics
Drug discovery company developing treatments for hormone resistant breast and prostate cancer patients
About Azeria Therapeutics
Azeria Therapeutics is a groundbreaking biotechnology company focused on developing innovative treatments for hormone-resistant breast and prostate cancers. Operating in the biopharmaceutical sector, Azeria serves patients with significant unmet clinical needs. The company leverages cutting-edge research on pioneer factors, specifically targeting the essential pioneer factor FOXA1, which plays a crucial role in the development and maintenance of estrogen receptor-positive luminal breast cancer and prostate cancer. Azeria's business model revolves around drug discovery and development, with revenue generated through investment funding and potential future drug sales. The company has secured significant financial backing, including Series A and Series B investments, to advance its research and development efforts. Azeria's clients include healthcare providers, research institutions, and pharmaceutical companies seeking advanced cancer treatments. The company aims to transform cancer care by providing breakthrough therapies that address critical gaps in current treatment options.
Source: Dealroom company dataNews
Open roles
Azeria Therapeutics in the Cambridge ecosystem
The Azeria Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- SCSixth Element Capital
Oxford University Innovation
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Azeria Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Azeria Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

